These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15946954)

  • 21. Understanding the drug-eluting stent trials.
    Coolong A; Kuntz RE
    Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular radiation in a drug-eluting stent world: it's not over till it's over.
    Teirstein PS; King S
    Circulation; 2003 Jul; 108(4):384-5. PubMed ID: 12885730
    [No Abstract]   [Full Text] [Related]  

  • 24. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis.
    Nordmann AJ; Briel M; Bucher HC
    Eur Heart J; 2006 Dec; 27(23):2784-814. PubMed ID: 17020889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A critical appraisal of the safety and efficacy of drug-eluting stents.
    Maluenda G; Lemesle G; Waksman R
    Clin Pharmacol Ther; 2009 May; 85(5):474-80. PubMed ID: 19279567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of stent design and coatings on restenosis and thrombosis.
    Hara H; Nakamura M; Palmaz JC; Schwartz RS
    Adv Drug Deliv Rev; 2006 Jun; 58(3):377-86. PubMed ID: 16650911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Off-label use of stents: bare-metal versus drug-eluting stents.
    Girod JP; Mulukutla SR; Marroquin OC
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1095-106. PubMed ID: 18793112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Cobalt chromium STent with Antiproliferative for Restenosis II (COSTAR II) trial study design: advancing the active-control evaluation of second-generation drug-eluting stents.
    Wang TY; Hasselblad V; Peterson JL; Wijns W; Parhizgar A; Kereiakes DJ; Krucoff MW
    Am Heart J; 2007 May; 153(5):743-8. PubMed ID: 17452147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The average stent length is longer and the average stent diameter is shorter in patients with drug-eluting stents versus bare-metal stents during percutaneous coronary intervention.
    Dilmanian H; Aronow WS; Mundia M; Pucillo AL; Weiss MB; Kalapatapu K; Monsen CE
    Am J Ther; 2007; 14(3):277-9. PubMed ID: 17515704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of drug-eluting stents in the coronary artery in ST-elevation myocardial infarction at a single high-volume medical center.
    Bose R; Gupta G; Grayburn PA; Laible EA; Kang MJ; Choi JW
    Am J Cardiol; 2007 Sep; 100(6):949-52. PubMed ID: 17826375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
    Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcomes following drug-eluting versus bare metal stent implantation for lesion subsets excluded from pivotal clinical trials: findings from the GHOST Study (Guthrie Health System Off-Label StenT Study).
    Harjai KJ; Orshaw P; Shenoy C; Acharji S; Sporn D; Aboufares A; Stapleton D
    J Interv Cardiol; 2008 Aug; 21(4):315-24. PubMed ID: 18754967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug-eluting or bare-metal stents in interventional cardiology. Theory and practice].
    Er F; Erdmann E
    Med Klin (Munich); 2007 Jan; 102(1):30-2. PubMed ID: 17221349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation.
    Zellweger MJ; Kaiser C; Brunner-La Rocca HP; Buser PT; Osswald S; Weiss P; Mueller-Brand J; Pfisterer ME;
    J Nucl Med; 2008 Apr; 49(4):550-6. PubMed ID: 18344439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current drug-eluting stents in complex patients and lesions.
    Elezi S; Dibra A; Schömig A; Kastrati A
    Minerva Cardioangiol; 2006 Feb; 54(1):5-22. PubMed ID: 16467738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The drug-eluting stent dilemma: comparing the effectiveness of Cypher versus Taxus.
    Biondi-Zoccai GG; Agostoni P; Sangiorgi GM; Colombo A
    J Cardiovasc Med (Hagerstown); 2006 Jan; 7(1):2-4. PubMed ID: 16645353
    [No Abstract]   [Full Text] [Related]  

  • 38. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial.
    Kelbaek H; Helqvist S; Thuesen L; Kløvgaard L; Jørgensen E; Saunamäki K; Krusell LR; Bøtker HE; Engstrøm T; Jensen GV;
    Am Heart J; 2006 Nov; 152(5):882-6. PubMed ID: 17070149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison.
    Mauri L; Orav EJ; Kuntz RE
    Circulation; 2005 Jun; 111(25):3435-42. PubMed ID: 15967844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary artery bypass is superior to drug-eluting stents in multivessel coronary artery disease.
    Guyton RA
    Ann Thorac Surg; 2006 Jun; 81(6):1949-57. PubMed ID: 16731112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.